Skip to content
Home/GPs/Seventure Partners
Seventure Partners

Seventure Partners

Paris, France·Founded 1983··seventure.fr

Seventure Partners is a European venture capital firm founded in 1997 and based in Paris, with €1 billion under management as of June 2024. It actively funds innovative companies in the fields of Digital technologies and Life sciences, supporting their growth and contributing to economic development in Europe.

AUM
€1.0B
Funds
9
vintages 2007–2022
Portfolio
123
Exits
10
SectorsHealthcareSoftwareConsumerBusiness Services

Key facts

HQParis, France
Founded1983

Recent exits

365Talents
Business Services · 2026 · 7yr hold
Saagie
Business Services · 2025 · 5yr hold
Wealthpilot
Fintech · 2025 · 5yr hold
DayTwo
Biotech · 2024 · 7yr hold

Coverage notes

9 funds tracked, 133 portfolio companies (123 active · 10 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund Seventure Partners has raised, with its portfolio companies. Hand-checked from public filings.

9 funds
Blue Forward FundGrowth
2022 · 4yr€130M10 active

Unrealized

10 held
ChemdocActive
EnergyFrance· Entry 2023
EnergyFrance· Entry 2020
Eauzons!Active
EnergyFrance· Entry 2023
GITActive
EnergyCanada· Entry 2022
EnergyNetherlands· Entry 2022
InalveActive
EnergyFrance· Entry 2022
EnergyFrance· Entry 2023
SinayActive
EnergyFrance· Entry 2022
SyrocoActive
EnergyFrance· Entry 2025
vorteX-ioActive
EnergyFrance· Entry 2026
Digital Opportunities Fund IIVC
2020 · 6yr€80M9 active · 1 realized

Unrealized

9 held
CitalidActive
FintechFrance· Entry 2022
GlopalActive
E-commerceFrance· Entry 2023
IdnowActive
FintechGermany· Entry 2026
MediadsActive
E-commerceFrance· Entry 2026
OpencellActive
FintechFrance· Entry 2021
OtoqiActive
E-commerceFrance· Entry 2020
PitchyActive
Business ServicesFrance· Entry 2023
ReelevantActive
E-commerceFrance· Entry 2026
WallixActive
Business ServicesFrance· Entry 2023

Realized

1 exit
SaagieExited 2025
Business ServicesFrance· Entry 2020
Trade Saleto
Health for Life Capital IIVC
2020 · 6yr€200M6 active

Unrealized

6 held
HealthcareFrance· Entry 2023
RevivBioActive
BiotechUS· Entry 2023
HealthcareInde· Entry 2023
TIBOTActive
HealthcareFrance· Entry 2020
TubulisActive
HealthcareGermany· Entry 2021
VirovetActive
HealthcareBelgium· Entry 2023
Sport & Performance CapitalVC
2019 · 7yr€80M17 active

Unrealized

17 held
AnybuddyActive
ConsumerFrance· Entry 2025
BaouwActive
ConsumerFrance· Entry 2023
bsportActive
ConsumerFrance· Entry 2023
Clim8Active
ConsumerFrance· Entry 2020
EkstereActive
ConsumerFrance· Entry 2025
ExoActive
ConsumerFrance· Entry 2024
FreejumpActive
ConsumerFrance· Entry 2022
GeoveloActive
ConsumerFrance· Entry 2022
HardloopActive
ConsumerFrance· Entry 2019
KariusActive
BiotechUS· Entry 2020
KarmenActive
FintechFrance· Entry 2022
KinomapActive
ConsumerFrance· Entry 2019
ConsumerFrance· Entry 2019
ConsumerFrance· Entry 2020
SportEasyActive
ConsumerFrance· Entry 2019
ConsumerFrance· Entry 2022
ZennizActive
ConsumerFinlande· Entry 2026
AVF FundVC
2018 · 8yr€24M1 active

Unrealized

1 held
AnimabActive
HealthcareBelgium· Entry 2020
Digital Opportunities FundVC
2017 · 9yr€56M19 active · 3 realized

Unrealized

19 held
FintechFrance· Entry 2020
FlexvelopActive
FintechGermany· Entry 2020
HackuityActive
Business ServicesFrance· Entry 2022
HepsterActive
FintechGermany· Entry 2020
HomerezActive
Business ServicesFrance· Entry 2013
IdeelActive
FintechFrance· Entry 2022
InspectoActive
HealthcareIsrael· Entry 2022
IzicapActive
FintechFrance· Entry 2020
JobteaserActive
Business ServicesFrance· Entry 2018
JolimoiActive
E-commerceFrance· Entry 2019
Business ServicesFrance· Entry 2022
FintechFrance· Entry 2021
Secure-ICActive
Business ServicesFrance· Entry 2020
SEKOIA.IOActive
Business ServicesFrance· Entry 2021
SentrycActive
E-commerceGermany· Entry 2021
SiitActive
FintechFrance· Entry 2022
SumupActive
FintechGermany· Entry 2019
FintechUK· Entry 2019
YesWeHackActive
Business ServicesFrance· Entry 2021

Realized

3 exits
365TalentsExited 2026
Business ServicesFrance· Entry 2019
Trade Saleto
FintechFrance· Entry 2018
Trade Saleto
WealthpilotExited 2025
FintechGermany· Entry 2020
Trade Saleto
Health for Life CapitalVC
2014 · 12yr€160M52 active · 3 realized

Unrealized

52 held
AbalosActive
BiotechGermany· Entry 2021
AllozymesActive
BiotechFrance· Entry 2022
BiotechJapan· Entry 2021
BiomXActive
BiotechIsrael· Entry 2017
MedTechGermany· Entry 2019
CattleEyeActive
HealthcareIreland· Entry 2021
CitryllActive
BiotechNetherlands· Entry 2021
BiotechDenmark· Entry 2023
BiotechBelgium· Entry 2021
CorWaveActive
MedTechFrance· Entry 2019
CytokiActive
BiotechDenmark· Entry 2023
DermalaActive
BiotechUS· Entry 2020
MedTechGermany· Entry 2020
EctoActive
HealthcareUS· Entry 2021
EligoActive
BiotechFrance· Entry 2019
EnteromeActive
BiotechFrance· Entry 2016
ErvimmuneActive
BiotechFrance· Entry 2022
BiotechUS· Entry 2022
FoodsmartActive
BiotechUS· Entry 2021
MedTechFrance· Entry 2016
HealthcareCanada· Entry 2026
KapseraActive
HealthcareFrance· Entry 2023
KebonyActive
BiotechNorway· Entry 2022
La VieActive
BiotechFrance· Entry 2022
LarqActive
BiotechUS· Entry 2020
LecturioActive
Business ServicesGermany· Entry 2020
BiotechFrance· Entry 2026
MachtfitActive
BiotechGermany· Entry 2018
MainstayActive
MedTechIreland· Entry 2022
Mauna KeaActive
MedTechFrance· Entry 2015
MedEyeActive
MedTechNetherlands· Entry 2019
MedinCellActive
HealthcareFrance· Entry 2017
BiotechUK· Entry 2026
BiotechUS· Entry 2020
NexessActive
TelecomFrance· Entry 2016
BiotechCanada· Entry 2023
NovobindActive
HealthcareCanada· Entry 2022
BiotechUS· Entry 2022
HealthcareSingapore· Entry 2023
HealthcarePoland· Entry 2022
ProtipActive
MedTechFrance· Entry 2016
QuantaActive
MedTechUK· Entry 2023
SequentiaActive
FoodTechSpain· Entry 2023
BiotechUS· Entry 2020
BiotechFrance· Entry 2026
StarfishActive
BiotechFrance· Entry 2023
SunriseActive
MedTechBelgium· Entry 2024
TargedysActive
BiotechFrance· Entry 2019
TestbirdsActive
Business ServicesGermany· Entry 2018
BiotechBelgium· Entry 2020
VedantaActive
BiotechUS· Entry 2020
BiotechUS· Entry 2023

Realized

3 exits
DayTwoExited 2024
BiotechIsrael· Entry 2017
Write-off
PixiumExited 2024
MedTechFrance· Entry 2014
Liquidation
PolarisExited 2023
BiotechFrance· Entry 2023
Secondaryto
Quadrivium 1 Seed FundVC
2013 · 13yr€56M8 active · 1 realized

Unrealized

8 held
AcarixActive
MedTechDenmark· Entry 2018
AlgoanActive
FintechFrance· Entry 2020
ArtifaktActive
Business ServicesFrance· Entry 2021
DashbookActive
E-commerceFrance· Entry 2022
FeetmeActive
MedTechFrance· Entry 2018
FIRE1Active
MedTechUK· Entry 2021
HealthcareDenmark· Entry 2018
HumedicsActive
MedTechGermany· Entry 2019

Realized

1 exit
BiomatlanteExited 2019
MedTechFrance· Entry 2016
Trade Saleto
Spef Pre-IPOVC
2007 · 19yr€30M1 active

Unrealized

1 held
MedTechFrance· Entry 2017
Track Seventure Partners

Saved GPs appear in your watchlist, one click from your workspace.

About Seventure Partners

Seventure Partners is a European venture capital firm with €1 billion of assets under management as of June 2024, founded in 1997 and headquartered in Paris. The firm specialises in Digital and Life Sciences themes with global recognition as a leading microbiome-focused investor through dedicated themed funds. Seventure operates as part of Natixis Investment Managers within the broader Groupe BPCE financial group.

Investment thesis

Seventure deploys venture capital across two complementary themes: Digital (enterprise software, fintech, digital media) and Life Sciences (biotech, MedTech, HealthTech with particular depth in microbiome and nutrition themes). Investment stages span early-stage seed and Series A through growth equity commitments. The microbiome thematic franchise distinguishes Seventure as one of the few European VCs with dedicated capital for that emerging scientific vertical, with equity tickets typically ranging from €1 million to €15 million per transaction.

Recent activity

Recent realised exits include 365Talents (business services, 2026), Saagie (business services, 2025), Medius Expensya (fintech, 2023) and Polaris (biotech, 2023), reflecting active distribution across the technology and life sciences franchises. The platform tracks 10 funds and 126 active portfolio companies across the multi-decade European VC programme. Detailed buyer names and multiple data available on Pro at €29/month.

Last updated June 2026 · Sourced from public filings